Bosley/Intercytex

[Henk]

BEVERLY HILLS, Calif., June 7 /PRNewswire/ -- There is something in the
air, or should we say in the hair, these days. Scientific research into hair
loss remedies has never been more active or more exciting. Consider:

* Bosley, through its sister company Aderans Research Institute,
continues to develop its research in hair multiplication (loosely
called hair cloning) as published in a recent Wall Street Journal
article. Bosley's parent company, Aderans, (8170-TSE) based in Tokyo,
realized an 18% gain in its stock following the publication of the
article.

The company just completed its initial discussion with the FDA last
week regarding this bio-technology approach to generate hair growth.

* Intercytex, with whom Bosley has a strategic relationship, is
conducting research in cellular-based hair multiplication biology and
tissue engineering in Manchester, England and plans to launch its IPO
on the UK stock exchange during the month of May.

* Per a recent Business Week article, a potential new class of drugs to
halt hair loss (and treat cancer!) is in the works by Curis, a small
bio-tech company, now leaping into the headlines with molecular-based
topical treatments

What does all this mean for the billion-dollar hair loss market? Hair is
big news. There are enormous business growth opportunities to come and even
better -- benefits to hair loss sufferers world-wide. A recent Roper study
confirms that baldness is a serious issue and that men would rather be bald
than face the world with thinning locks, or the dreaded comb-over. In
addition to the tens of millions of men with hair loss in America, there are
in excess of 30 million women suffering from hair loss.
Ken Washenik, M.D., Ph.D., Medical Director of Bosley and a world-renowned
hair loss expert, directs the research at Aderans Research Institute. "We are
very excited at how well our research in hair multiplication has progressed.
We are very close to the first time in history when the number of hairs on the
scalp can be increased significantly." John Ohanesian, President and CEO of
Bosley, states, "the hair loss market is exploding! Bosley is the world's
largest hair restoration enterprise and because of our association with
Aderans and ARI, we are uniquely positioned to become the driver of this
revolution in hair loss solutions."

Phone and in-person interviews available.


SOURCE Bosley


Bron:
http://www.prnewswire.com/cgi-bin/st...3821470&EDATE=

[Tiuri]

waar gaat dit over?

[Henk]

Oorspronkelijk geplaatst door laurensj

waar gaat dit over?

Bosley (een groot amerikaans ht-kliniek) heeft een samenwerkingsverband met Intercytex.
Intercytex is al een tijdje bezig met het ontwikkelen van haarmultiplicatie.
Volgens hun duurt het nu niet lang meer voordat het op de markt komt.
Maar "niet lang" kan nog heel lang duren als je er op wacht.

[rizla]

het lijkt er tenminste op dat dit toch echt een heel bedrijf is... heb dr meer vertrouwen in dan in onze eigen gho